Rapid Digitalization Using Digoxin

Introduction to Rapid Digitalization

The American College of Cardiology recommends that rapid digitalization with digoxin should generally be avoided in favor of IV beta-blockers or direct-current cardioversion for acute hemodynamic instability (Class I) 1, 2

Digoxin may only be considered for acute rate control in the limited scenario of acute heart failure with severe LV dysfunction AND atrial fibrillation with rapid ventricular response when beta-blockers are contraindicated or have failed (Class IIb, Level C) 1, 2

The American Heart Association advises against using digoxin in patients with second- or third-degree heart block without a permanent pacemaker 1, 2, 3
The American College of Cardiology recommends avoiding digoxin in patients with pre-excitation syndromes (Wolff-Parkinson-White), as it can accelerate ventricular rate and precipitate ventricular fibrillation (Class III: Harm) 1, 2

The American College of Cardiology recommends direct-current cardioversion as the Class I treatment for new-onset AF with hemodynamic compromise 1, 2
The American Heart Association suggests IV beta-blockers as first-line treatment for acute rate control without hemodynamic collapse (Class I, Level B) 1, 2
The American College of Cardiology recommends IV amiodarone as an alternative for acute rate control (Class I, Level B for HF; Class IIa, Level C for other settings) 1, 2

The American College of Cardiology advises transitioning to oral maintenance dosing of 0.125 mg daily for patients >70 years, renal impairment, or low lean body mass, and 0.25 mg daily for younger adults with normal renal function 3

The American Heart Association warns against using loading doses in stable outpatients, as gradual accumulation over 1-3 weeks is safer 3
The American College of Cardiology recommends not relying on digoxin alone for acute rate control, as combination with beta-blocker is more effective 1, 2